PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: SNAP-8, Acetyl Octapeptide-3
SNAP-8 (Acetyl Octapeptide-3) is a topical cosmetic peptide marketed as a needle-free alternative for softening expression lines by reducing muscle contraction at the surface. It is an elongated analog of the Argireline hexapeptide.
Sign in to rate this peptide.
SNAP-8 is Acetyl Octapeptide-3, an eight-amino-acid peptide derived from the N-terminus of SNAP-25. It is designed to compete with native SNAP-25 within the SNARE protein complex required for neurotransmitter vesicle docking and fusion at the neuromuscular junction. By interfering with SNARE complex assembly, it is theorized to reduce acetylcholine release and thereby attenuate the strength of facial muscle contractions that produce dynamic expression lines. Applied topically, the effect is local and reversible, in contrast to the enzymatic cleavage produced by botulinum toxin, and it is frequently formulated alongside Argireline (Acetyl Hexapeptide-3/8).